Bioengineering the lung

D. Weiss (Burlington, United States of America)

Source: Research Seminar 2014 - The many faces of stem cells in respiratory diseases
Number: 9

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Weiss (Burlington, United States of America). Bioengineering the lung. Research Seminar 2014 - The many faces of stem cells in respiratory diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Disease 2019
Source: ERJ Open Res, 6 (4) 00123-2020; 10.1183/23120541.00123-2020
Year: 2020



Aspergillus spp. colonization in exhaled breath condensate of lung cancer patients from Puglia Region of Italy
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014


National lung cancer tissue diagnosis targets: Are they achievable?
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

Interventional Pulmonary Medicine. Lung Biology in Health and Disease
Source: Eur Respir J 2005; 25: 583
Year: 2005


Use of decellularized tracheas for airways engineering
Source: International Congress 2016 – Current challenges in thoracic surgery
Year: 2016

Research at the Unit of Lung and Allergy research at Karolinksa Intitutet, Stockholm, Sweden
Source: Eur Respir Rev 2008; 17: 15-17
Year: 2008


Cetuximab administered through pulmonary route in a mice model of lung tumor
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013


Mechanistic overlap between chronic lung injury and cancer: ERS Lung Science Conference 2017 report
Source: Eur Respir Rev, 26 (144) 170060; 10.1183/16000617.0060-2017
Year: 2017



Lymphocyte profile in the BALF from affected lung in comparison to healthy lung and systemic inflammation in lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Bronchiolo-alveolar carcinoma- sometimes a difficult diagnosis
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

The value of miR221 and miR222 as a biomarker in non small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Cell–matrix interactions in lung disease and regeneration: ERS Lung Science Conference 2018 report
Source: Eur Respir Rev, 27 (148) 180040; 10.1183/16000617.0040-2018
Year: 2018



Lung Cancer and bronchial infection
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017

Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014

Lung Micobiome in Lung Cancer
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020


Exhaled breath temperature in NSCLC: Could be a new non invasive marker?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014



The research on early detection of lung cancer with exhaled volatile organic compounds
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

The provision of EBUS-TBNA services across a UK lung cancer network; a report from the Greater Manchester and Cheshire Lung Cancer Network EBUS Sub-Group
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014